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Introduction
The α-galactosylceramide (α-GalCer, KRN7000) 1 and several other structurally related bacterial glycolipids such as the glucuronic acid containing 2 interact with natural killer T (NKT) cells when bound to the glycoprotein CD1d (Fig 1.) . 1, 2 This recognition event promotes an immune response leading to the production of T helper 1 (Th1) and T helper 2 (Th2) cytokines, such as interferon-γ (IFN-γ) and interleukin 4 (IL-4). 3 The production of Th1 cytokines assists against various types of infection, whereas Th2 cytokines assist with the alleviation of autoimmune diseases. The Th1 and Th2 cytokines tend to inhibit each other's biological functions and α-GalCer stimulates the production of high levels of these cytokines. However, there is a lack of discrepancy between the Th1 and Th2 response to α-GalCer and many glycolipid antigens have been synthesized in efforts to generate bias. Structural modifications investigated to date have included varying of the sugar moiety, as well as the polar portion of the ceramide, the lipid chain and the nature and configuration of the anomeric linkage. Some analogues have shown promising results. Wong and co-workers have introduced a fluorinated biaryl ether derivative 3, which showed enhanced Th1 cytokine production. 4 Glycosidic bond modifications have been investigated for reasons which include limiting the degradation of glycolipid antigens by glycosidases, and with a view to investigating whether such derivatives can display bias towards the production of the Th1 or Th2 cytokines. Modifications at the anomeric position have included synthesis of S-, and C-glycolipids and oxime derivatives. There is continuing interest in the synthesis of analogues. Glycosyl triazoles have been of increased interest in recent years with such neoglycoconjugates being evaluated as lectin binding agents. 6 Despite this research, variants of the glycosphingolipids which have an α-1,2,3-triazole linkage at the anomeric position (glycosyl triazole) have not been synthesized to date and they would be of interest to prepare. While glycosyl azides have been used as intermediates in preparation of carbohydrate derivatives, work has focused mostly on β-azides with there being few investigations using α-glycosyl azides to date. In the case of these immunostimulatory glycolipids, having the α-configuration at the anomeric carbon seems to be very important. The insertion of a triazole between the anomeric carbon and the carbon atom adjacent to the lipid nitrogen atom alters the spatial orientation between the sphinogolipid and the saccharide. A simple molecular modeling comparison between 2 2 and 5 indicated that the distance between the carbon adjacent to to the carbon atom adjacent to the lipid nitrogen and the anomeric carbon increases by ~1.2 Å. The triazole atoms potentially have interactions with the CD1d receptor. We describe herein the preparation of the galacturonic acid and galactose derivatives 4 and 5.
Results and Discussion

Synthesis
The retrosynthetic analysis of 4 and 5 is shown in Scheme 1. It was envisaged that the 1,4-triazole glycolipid 4 would be generated by the copper azide-alkyne cycloaddition reaction (CuAAC) 7 between α-glycosyl azide 6 8 and alkyne 7. In turn, the alkyne 7 would be generated from aldehyde 9. We envisaged that the anomerisation of the β-azide 8 to give the required α-azide precursor 6.
Scheme 1. Retrosynthetic analysis of glycolipids with an α-triazole
The synthesis began with the preparation of 7 (Scheme 2). The pseudoephedrine chiral auxiliary 10 was used as described previously for the preparation of the aldehyde 9. 9 The OhiraBestmann modification of the Seyferth-Gilbert homologation has provided mild conditions for the preparation of terminal alkynes from aldehydes.
10 Reaction of 9 with the Ohira-Bestmann reagent 11 provided the alkyne 12 in 87% yield. Treatment of 12 with formic acid 11 for 2 h removed both the oxazolidine and Boc protecting groups and gave the sphinganine 13 which was immediately reacted with succinate 14 12 to give the desired glycolipid precursor 7. Overall the lipid 7 was obtained in 9 steps from the glycinamide 10. The synthesis of α-glycosyl azide 6 was next carried out (Scheme 3) by a procedure modified from that in the recent literature. 8 Firstly, the methyl ester 16 was prepared in 2 steps from galacturonic acid 15 as previously described. 8 Next the introduction of the azide at the anomeric center using SnCl 4 (3 eq.) and TMSN 3 (2.5 eq.) 13 was investigated in order to try to effect glycosidation and anomerisation in one pot. The exchange of the acetate for azide can usually be effected in the presence of 0.5 eq of SnCl 4 . In this case the higher amount of SnCl 4 was needed in order to ensure full conversion of 16 to glycosyl azide. This glycosidation provided a mixture of 4:1 mixture of anomers 6 and 8, which could not be separated. Lewis acids such SnCl 4 and TiCl 4 have been shown to promote chelate induced anomerisation in uronic acid O-, S-and N 3 glycoside derivatives and these reactions can proceed in high yield and selectivity for the -anomer.
Scheme 2. Synthesis of alkyne 7
Coordination of the pyranose ring oxygen and the C-5 carbonyl to the Lewis acid increases the anomerisation rate, promoting endocyclic cleavage leading to the more thermodynamically favored α-anomer in high selectivity. Hence the formation of the α-azide as the major anomer is due to Sn(IV) promoted anomerisation of the initially formed β-azide 8. 8 In order to further increase the proportion of the α-azide, the mixture was treated with TiCl 4 (2.5 fold excess) as the α:β ratio in such anomerisation reactions can be influenced by the concentration of TiCl 4 . The effect of TiCl 4 on anomerisation ratio can be explained by coordination of this more active Lewis acid to the anomeric azide, increasing the electron withdrawing nature of the anomeric substituent and thus enhancing the anomeric effect. The α:β ratio was not just dependent on TiCl 4 concentration but also on temperature and the α-selectivity was found to be higher at -15°C than at room temperature. Next, the selective cleavage of methyl ester 6 to its carboxylic acid derivative was achieved by heating with LiI in EtOAc at reflux. 14 Chemoselective reduction of the acid with BH 3 .THF followed by acetylation successfully provided the galactosyl azide 17.
15
Scheme 3. Synthesis of α-azides 6 and 17
With the glycosyl azides 6 and 17 in hand the synthesis of the triazole linkage was then explored. The copper catalysed version of the Huisgen azide-alkyne cycloaddition has been an important advance in the preparation of 1,2,3-triazoles and this reaction usually provides the 1,4-isomer in a highly regioselective manner. The glycolipid 18 was prepared as depicted in Scheme 4. On using microwave conditions described by Opatz and coworkers, 18 was obtained in 65% yield. 16 The reaction was highly selective, giving only the 1,4 isomer. Removal of the protecting groups from 18 then gave target compound 4. As previously described for the deprotection of uronic acid derivatives, the removal of the protecting groups was achieved using hydroperoxide generated in n-propanol from sodium propoxide and hydrogen peroxide. 17 The use of methoxide, which is more basic than peroxide, can lead to the elimination of acetic acid and the formation of the undesired saturated compound. The synthesis of the 1,4-triazole galactose derivative 5 was achieved by a similar sequence from the azide 17. The CuAAC reaction from 17 provided the triazole in 68% yield and subsequent removal of protecting groups gave 5 in 86% yield. 
Conclusion
To conclude, the synthesis of α-glycolipids based on galactose and galacturonic acid, and with a triazole at the anomeric position has been achieved. The route included anomerisation to generate the α-azide of galacturonic acid, which was subsequently converted to the galactose derivative. Microwave assisted CuAAC from these α-azides led to the generation of the desired triazole linkage. Consequently the evaluation of the immunostimulatory potential of such glycolipids will be of interest.
Experimental section
General
Optical rotations were determined at the sodium D line at 20°C. NMR spectra were recorded at 500 & 600 MHz. 1 H NMR signals were assigned with the aid of COSY and 13 C NMR signals were assigned with the aid of DEPT, gHSQCAD and/or gHMBCAD. Coupling constants are reported in Hertz. The IR spectra were recorded using thin film with an ATR attachment. High resolution mass spectra were recorded using electrospray TOF spectrometry. Silica gel used had a pore size 60 Å, particle size 40-60 μm 230-400 mesh particle size. Dichloromethane, methanol, THF and DMF solvents were used as obtained from a Pure Solv™ Solvent Purification System. DMA, ethyl acetate and acetone were used as obtained from commercial suppliers. Reagents were used as obtained from commercial suppliers.
(4S,5R)-t-Butyl-5-heptadecyl-2,2-dimethyl-4-(prop-1-enyl)-oxazolidine-3-carboxylate
This alkene precursor to aldehyde 9 was synthesised according to previously reported procedures detailed in ref. 9 
(4S,5R)-t-Butyl-5-heptadecyl-4-(formyl)-2,2 dimethyloxazolidine-3-carboxylate (9)
To a solution of alkene described above (194 mg, 0.41 mmol) in 10:1 acetone-water (3.9 mL) were added, 2,6-lutidine (0.1 mL. 0.82 mmol), 4-methylmorpholine-N-oxide (72 mg, 0.615 mmol) and a catalytic amount of osmium tetroxide (0.1 mL of 2.5% in tBuOH, 2 mol%). The solution was stirred vigorously for 2 days. Then PhI(OAc) 2 (264 mg, 0.82 mmol) was added and the mixture stirred for a further 3 h. The reaction was quenched with aq sodium thiosulphate and then extracted into EtOAc (x 2). The combined organic portions were washed with water, brine, dried over Na 2 SO 4 and the solvent was removed under reduced pressure. Flash chromatography of the residue (petroleum etherEtOAc 30:1) provided 9 (117 mg, 61%) as a colourless oil; IR (film) cm 
(4S,5R)-t-Butyl-5-heptadecyl-4-(ethynyl)-2,2-dimethyloxazolidine-3-carboxylate (12)
Under an argon atmosphere, aldehyde 9 (111 mg, 0.24 mmol) and the Ohira-Bestmann reagent 11 (0.1 mL, 0.72 mmol) were taken up in dry methanol (1.1 mL) and cooled to 0 °C. Potassium carbonate (133 mg, 0.96 mmol) was added and the reaction mixture was stirred at 0 °C for 1 h, warmed to room temperature and stirred for a further 16 h. The reaction was diluted with satd NH 4 Cl and then extracted into EtOAc (x 2). The combined organic layers were dried over Na 2 
N-((3S,4R)-4-Hydroxyhenicos-1-yn-3-yl)nonadecanamide (7)
Alkyne 12 (90 mg, 0.19 mmol) was taken up in formic acid (6 mL) and stirred vigorously for 2 h. Toluene (15 mL) was added and the solvents were removed under reduced pressure. The resulting residue was taken up in water and basified with solid NaHCO 3, extracted into CH 2 Cl 2, dried over Na 2 SO 4 and solvent removed under reduced pressure to give intermediate amine 13. This was taken up in CH 2 Cl 2 (6 mL) and DIPEA (0.12 mL, 0.68 mmol) was added. To this was added a solution of 14 (192 mg, 0.49 mmol) in CH 2 Cl 2 (3 mL) and the mixture stirred for 24 h. Upon completion the reaction mixture was diluted with CH 2 Cl 2 , washed with satd aq NaHCO 3 and then extracted into CH 2 Cl 2 (x2). The combined organic layers were washed with water, brine, dried over Na 2 
1,2,3,4-Tetra-O-acetyl-α-D-galactopyranosiduronic acid, methyl ester (16).
To a stirred solution of HClO 4 (220 µL) in Ac 2 O (57 mL) at 0°C was added D-galacturonic acid monohydrate 15 (10 g, 52 mmol) in one portion. The reaction was warmed to room temperature and then stirred for 3 h. The reaction was then recooled to 0 °C and MeOH was added cautiously. After stirring for a further 30 min the reaction was partitioned between EtOAc and H 2 O. The aq layer was extracted into EtOAc (x 2) and the combined organic layers were washed with water, brine, dried over Na 2 SO 4 and the solvent removed under reduced pressure. The resulting residue was azeotroped several times with toluene to remove acetic acid. Once removed the residue was taken up in DMF (58 mL). Sodium hydrogen carbonate (8.3 g, 100 mmol) and iodomethane (8.1 mL, 130 mmol) were added and the solution was stirred overnight. 
1-Azido-1-deoxy-2,3,4-tri-O-acetyl-D-galactopyranuronic acid, methyl ester (6&8)
Methyl ester 16 (10 g, 26.6 mmol) and trimethylsilyl azide (8.7 mL, 67 mmol) were taken up in dry CH 2 Cl 2 (100 mL) and cooled to 0 °C. Tin (IV) chloride (9.4 mL, 80 mmol) was added dropwise. The resulting solution was warmed to room temperature and stirred for 24 h. The mixture was diluted with CH 2 Cl 2 washed with 1M KHSO 4 , satd. NaHCO 3 , water and brine, dried over Na 2 
1-Azido-1-deoxy-2,3,4-tri-O-acetyl-α-D-galactopyranuronic acid, methyl ester (6)
To a stirred solution of the mixure of anomers 6 and 8 (1.2 g, 3.34 mmol) in dry CH 2 Cl 2 (15 mL) at 0 °C was added 1M TiCl 4 in CH 2 Cl 2, (8.35 mL) dropwise. The solution was stirred at 0 °C for 10 minutes and then placed in a fridge freezer at -15 °C for 48 h. The reaction mixture was then diluted with CH 2 Cl 2, washed twice with sat. NaHCO 3 , water, brine, dried over NaSO 4 and solvent removed under reduced pressure. Flash chromatography of the residue (petroleum ether-EtOAc 2:1) provided the title compound 6 (987 mg, 82%) as a white foam; NMR data ( 1 H and 13 C) were in good agreement with the reported literature data; 8 -. This acid intermediate (100 mg, 0.29 mmol) was taken up in dry THF (3 mL) and cooled to 0 °C. To this was added BF 3 .THF complex (0.9 mL of a 1.0 M solution in THF, 0.9 mmol) dropwise. The reaction was warmed to room temperature and stirred overnight. Methanol was added and the solvents were removed under reduced pressure. The crude residue was taken up in Ac 2 O (2 mL) and pyridine (2 mL) and stirred for a further 4 hours. The reaction was diluted with EtOAc, washed with 1M HCl, water, brine, dried over Na 2 SO 4 and solvent removed under reduced pressure. Flash chromatography of the residue (petroleum ether-EtOAc 2:1) provided the title compound 17 (70 mg, 65% over two steps) as a crystalline solid; NMR data ( 1 H and 13 C) were in good agreement with the reported literature data; 15 Alkyne 7 (15 mg, 0.025 mmol) was dissolved in N, Ndimethylformamide (1.5 mL). After addition of azide 6 (14 mg, 0.038 mmol), copper(I)iodide (1 mg, 0.005 mmol) and N,Ndiiosopropyl-ethylamine (9 µL), the reaction mixture was placed in a microwave reactor for 60 min, at 80 °C and 120 W. The resulting solution was diluted with EtOAc and washed with H 2 O (3 x 10 mL). The organic layer was dried over Na 2 
N-((1S,2R)-2-Hydroxy-1-(1-(5-(S)-hydroxycarbonyl-β-Larabinopyranosyl)-1H-1,2,3-triazol-4-yl)nonadecyl)nonadecanamide (4)
The protected lipid 18 (13.6 mg, 14 µmol) was dissolved in nPrOH (3.4 mL) and H 2 O 2 (0.34 mL of 30% aq solution). To this was added n-PrONa/n-PrOH (850 µL of an 0.1 M solution in nPrOH, , 85 µmol) dropwise at a rate of 100 µL/h. After addition was completed the reaction was stirred for a further 1 h. Water (9 mL) was added and the solution centrifuged at 15000 rpm for 15 min. The supernatant was removed and the precipitate treated a further two times with water. The precipitate was lyophilised to provide the title compound 4 (6.6 mg, 57%) as a white solid; 1 H NMR (600 MHz, CD 3 -. The protected lipid (7 mg, 7.2 µmol) was dissolved in n-PrOH (1 mL) and H 2 O 2 (30%, 0.12 mL). To this was added n-PrONa (430 µL of an 0.1 M solution in n-PrOH, 43 µmol,) dropwise at a rate of 100 µL/h. After the addition was completed the reaction was stirred for a further 1 h. Water (4 mL) was then added and the solution centrifuged at 15000 rpm for 15 min. The supernatant was removed and the precipitate treated a further two times with water. The precipitate was lyophilised to provide the title compound 5 (5 mg, 86%) as a white solid; 
